IP Library Granted Patent US 12,359,071
Granted Patent B2
US 12,359,071 · App. 18/618,544 · Granted Jul 15, 2025

Polymeric tandem dyes with linker groups

Inventors: Tracy Matray (Snohomish, WA); Michael VanBrunt (Bothell, WA)
Assignee: Sony Group Corporation
C09B69/10C07F9/098C07F9/65586G01N21/6428G01N33/582G01N2021/6439
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,359,071
App. No.
18/618,544
Granted
Jul 15, 2025
Kind
B2
Abstract

Compounds useful as fluorescent or colored dyes are disclosed. In some embodiments, the compounds have the following structure (I): or a stereoisomer, tautomer or salt thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 , L 1 , L 2 , L 3 , L 4 , M 1 , M 2 , m, and n are as defined herein. Methods associated with preparation and use of such compounds is also provided.

Claims (78)

1. A polymer compound comprising:

A Förster resonance energy transfer (FRET) acceptor chromophore having an acceptor transition dipole moment and being covalently linked to a polymer backbone; and

a FRET donor chromophore having a donor transition dipole moment and being covalently linked to the polymer backbone,

wherein:

the FRET acceptor chromophore and the FRET donor chromophore have a J-value greater than about 1×10 10 and the polymer compound adopts a confirmation in solution at physiological conditions wherein the effective distance between the FRET acceptor chromophore and the FRET donor chromophore is less than about 50.0 nm and the acceptor transition dipole and the donor transition dipole are substantially parallel or substantially antiparallel, and

the polymer backbone has the following structure:

wherein:

R 4 is, at each occurrence, independently OH, SH, O − , S − , OR d or SR d ;

R 5 is, at each occurrence, independently oxo, thioxo or absent;

L 4 is, at each occurrence, independently an alkylene or heteroalkylene linker;

and

m is, at each occurrence, independently an integer of one or greater.

2. The polymer compound of claim 1 , wherein the compound has the following structure (I):

or a stereoisomer, salt, or tautomer thereof, wherein:

M 1 and M 2 are, at each occurrence, independently a chromophore, provided that at least one of M 1 and M 2 is a FRET donor chromophore, and another one of M 1 and M 2 is a corresponding FRET acceptor chromophore, and at least one occurrence a FRET donor chromophore is positioned between two FRET acceptor chromophores;

L 1 is, at each occurrence, an optional linker, provided that at least one occurrence of L 1 is present and comprises oxygen;

L 2 and L 3 are, at each occurrence, independently an optional alkylene, alkenylene, alkynylene, heteroalkylene, heteroalkenylene, heteroalkynylene or heteroatomic linker;

L 4 is, at each occurrence, independently an alkylene or heteroalkylene linker;

R 1 is, at each occurrence, independently H, alkyl or alkoxy;

R 2 and R 3 are each independently H, OH, SH, alkyl, alkoxy, alkylether, heteroalkyl, —OP(═R a )(R b )R c , Q, or a protected form thereof, or L′;

R 4 is, at each occurrence, independently OH, SH, O − , S − , OR d or SR d ;

R 5 is, at each occurrence, independently oxo, thioxo or absent;

R a is O or S;

R b is OH, SH, O − , S − , OR d or SR d ;

R c is OH, SH, O − , S − , OR d , OL′, SR d , alkyl, alkoxy, heteroalkyl, heteroalkoxy, alkylether, alkoxyalkylether, phosphate, thiophosphate, phosphoalkyl, thiophosphoalkyl, phosphoalkylether or thiophosphoalkylether;

R d is a counter ion;

Q is, at each occurrence, independently a moiety comprising a reactive group, or protected form thereof, capable of forming a covalent bond with an analyte molecule, a targeting moiety, a solid support, or a complementary reactive group Q′;

L′ is, at each occurrence, independently a linker comprising a covalent bond to Q, a linker comprising a covalent bond to a targeting moiety, a linker comprising a covalent bond to an analyte molecule, a linker comprising a covalent bond to a solid support, a linker comprising a covalent bond to a solid support residue, a linker comprising a covalent bond to a nucleoside or a linker comprising a covalent bond to a further compound of structure (I);

m is, at each occurrence, independently an integer of one or greater; and

n is an integer of two or greater.

3. The polymer compound of claim 2 , wherein the compound has the following structure (IA):

wherein:

z is, at each occurrence, independently an integer from 1 to 100; and

m is, at each occurrence, independently an integer from 10 to 6.

4. The polymer compound of claim 3 , wherein z is, at each occurrence, independently an integer from 1 to 30.

5. The polymer compound of claim 3 , wherein m is, at each occurrence, independently an integer from 2 to 4.

6. The polymer compound of claim 3 , wherein the compound has the following structure (IB):

wherein:

x 1 , x 2 , x 3 , and x 4 are, at each occurrence, independently an integer from 0 to 6.

7. The polymer compound of claim 1 , wherein L 1 comprises one of the following structures:

wherein a, b, and c are each independently an integer ranging from 1 to 6.

8. The polymer compound of claim 2 , wherein R 4 is, at each occurrence, independently OH, O − or OR d ; R 5 is, at each occurrence, oxo; and R 1 is, at each occurrence, H.

9. The polymer compound of claim 2 , wherein one of R 2 or R 3 is OH or —OP(═R a )(R b )R c , and the other of R 2 or R 3 is Q or a linker comprising a covalent bond to Q.

10. The polymer compound of claim 2 , wherein Q has one of the following structures:

wherein each X is independently a halogen.

11. The polymer compound of claim 2 , wherein one of R 2 or R 3 is OH or —OP(═R a )(R b )R c , and the other of R 2 or R 3 is a linker comprising a covalent bond to an analyte molecule or a linker comprising a covalent bond to a solid support.

12. The polymer compound of claim 2 , wherein R 2 or R 3 has one of the following structures:

13. The polymer compound of claim 2 , wherein at least one combination of M 1 and M 2 is a FRET pair with a J-value greater than about 1×10 11 .

14. The polymer compound of claim 2 , wherein M 1 and M 2 are, at each occurrence, independently selected from the group consisting of:

i) a dimethylaminostilbene, quinacridone, fluorophenyl-dimethyl-4,4-difluoro-4-bora-3a 4a-diaza-s-indacene, his-fluorophenyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene, acridine, terrylene, sexiphenyl, porphyrin, benzopyrene, (fluorophenyl-dimethyl-difluorobora-diaza-indacene) phenyl, (bis-fluorophenyl-difluorobora-diaza-indacene) phenyl, quaterphenyl, bi-benzothiazole, ter-benzothiazole, bi-naphthyl, bi-anthracyl, squaraine, squarylium, 9,10-ethynylanthracene, and ter-naphthyl moiety;

ii) p-terphenyl, perylene, azobenzene, phenazine, phenanthroline, acridine, thioxanthrene, chrysene, rubrene, coronene, cyanine, perylene imide, perylene amide, and derivatives thereof;

iii) a coumarin dye, resorufin dye, dipyrrometheneboron difluoride dye, ruthenium bipyridyl dye, thiazole orange dye, polymethine, and N-aryl-1,8-naphthalimide dye; or

iv) a coumarin dye, boron-dipyrromethene, rhodamine, cyanine, pyrene, perylene, perylene monoimide, 6-carboxyfluorescein, 5-carboxyfluorescein, 6-FITC, 5-FITC, and derivatives thereof.

15. The polymer compound of claim 2 , wherein M 1 and M 2 form a FRET pair, wherein M 1 and M 2 at each occurrence, independently have one of the following structures:

16. The polymer compound of claim 2 , wherein the compound is selected from:

wherein:

Bs has the following structure:

FITC has the following structure:

AF555 has the following structure:

Cy3 has the following structure:

AF700 refers to Alexa Fluor 700 having a CAS Registry No. of 1246956-22-8;

AF680 has the following structure:

AF647 has the following structure:

AF350 has the following structure:

PB has the following structure:

AF594 has the following structure:

and

dT has the following structure:

wherein R is H or a direct bond.

17. A composition comprising the polymer compound of claim 1 and one or more analyte molecules.

18. A method for visually detecting an analyte molecule, the method comprising:

(a) providing the polymer compound of claim 2 , wherein the polymer compound comprises a covalent bond to the analyte molecule; and

(b) detecting the polymer compound by its visible properties.

19. A method for visually detecting an analyte molecule, the method comprising:

(a) ad-mixing the polymer compound of claim 2 , wherein the polymer compound comprises a covalent bond to Q, with the analyte molecule;

(b) forming a bio-conjugate of the polymer compound and the analyte molecule; and

(c) detecting the bio-conjugate by its visible properties.

20. A method of staining a sample, comprising adding to said sample the compound of claim 2 in an amount sufficient to produce an optical response when said sample is illuminated at an appropriate wavelength.

Continuity (5)
Continuation 17735947 · May 3, 2022
Division 17242106 · Apr 27, 2021
Continuation PCTUS2020052754 · Sep 25, 2020
Provisional Application 62906591 · Sep 26, 2019
Related Publication 20240294767A1 · Sep 5, 2024
References Cited (394)
US 4450305A · Kamhi · 1984 [cited by applicant]
US 4476229A · Fino et al. · 1984 [cited by applicant]
US 4778753A · Yamanishi et al. · 1988 [cited by applicant]
US 5053054A · Kirchanski · 1991 [cited by applicant]
US 5268486A · Waggoner et al. · 1993 [cited by applicant]
US 5318894A · Pugia · 1994 [cited by applicant]
US 5582977A · Yue et al. · 1996 [cited by applicant]
US 5698391A · Cook et al. · 1997 [cited by applicant]
US 5886177A · Cook et al. · 1999 [cited by applicant]
US 5994143A · Bieniarz et al. · 1999 [cited by applicant]
US 6005093A · Wood et al. · 1999 [cited by applicant]
US 6140480A · Kool · 2000 [cited by applicant]
US 6171859B1 · Herrnstadt et al. · 2001 [cited by applicant]
US 6218108B1 · Kool · 2001 [cited by applicant]
US 6365730B1 · Jennings et al. · 2002 [cited by applicant]
US 6380431B1 · Whipple et al. · 2002 [cited by applicant]
US 6479650B1 · Kool · 2002 [cited by applicant]
US 6514700B1 · Singh · 2003 [cited by applicant]
US 6534041B1 · Licha et al. · 2003 [cited by applicant]
US 6627400B1 · Singh et al. · 2003 [cited by applicant]
US 6670193B2 · Kool · 2003 [cited by applicant]
US 6716452B1 · Piccariello et al. · 2004 [cited by applicant]
US 6852709B2 · Leong et al. · 2005 [cited by applicant]
US 7038063B2 · Lee et al. · 2006 [cited by applicant]
US 7060708B2 · Piccariello et al. · 2006 [cited by applicant]
US 7172907B2 · Chen et al. · 2007 [cited by applicant]
US 7423133B2 · Kool et al. · 2008 [cited by applicant]
US 7667024B2 · Mao et al. · 2010 [cited by applicant]
US 7897684B2 · Bazan et al. · 2011 [cited by applicant]
US 8008522B2 · Lukhtanov et al. · 2011 [cited by applicant]
US 8101776B2 · Berens et al. · 2012 [cited by applicant]
US 8153706B2 · Vasudevan · 2012 [cited by applicant]
US 8217389B2 · Nakano et al. · 2012 [cited by applicant]
US 8293700B2 · Arranz · 2012 [cited by applicant]
US 8349308B2 · Yurkovetskiy et al. · 2013 [cited by applicant]
US 8354515B2 · Ueno et al. · 2013 [cited by applicant]
US 8431545B2 · Kataoka et al. · 2013 [cited by applicant]
US 8491993B2 · Nguyen et al. · 2013 [cited by applicant]
US 8546590B2 · Gall · 2013 [cited by applicant]
US 8632947B2 · Bentley et al. · 2014 [cited by applicant]
US 8802738B2 · Emrick · 2014 [cited by applicant]
US 8895023B2 · Rademacher et al. · 2014 [cited by applicant]
US 8906603B2 · Castro et al. · 2014 [cited by applicant]
US 8946394B2 · Na et al. · 2015 [cited by applicant]
US 9029537B2 · Koch · 2015 [cited by applicant]
US 9085799B2 · Bazan et al. · 2015 [cited by applicant]
US 9150782B2 · Lee et al. · 2015 [cited by applicant]
US 9400273B1 · Liu et al. · 2016 [cited by applicant]
US 9545447B2 · Wooley et al. · 2017 [cited by applicant]
US 9649389B2 · Groves et al. · 2017 [cited by applicant]
US 9687291B2 · Shimizu et al. · 2017 [cited by applicant]
US 9689877B2 · Matray et al. · 2017 [cited by applicant]
US 9696310B2 · Margulies et al. · 2017 [cited by applicant]
US 9714946B2 · Bradner et al. · 2017 [cited by applicant]
US 9765220B2 · Matray et al. · 2017 [cited by applicant]
US 9822134B2 · Segev · 2017 [cited by applicant]
US 9851359B2 · Matray et al. · 2017 [cited by applicant]
US 9884070B2 · Denardo et al. · 2018 [cited by applicant]
US 9910051B2 · Beacham et al. · 2018 [cited by applicant]
US 9913992B2 · Demarest et al. · 2018 [cited by applicant]
US 9932578B2 · Feinstein et al. · 2018 [cited by applicant]
US 9939454B2 · Dzubay et al. · 2018 [cited by applicant]
US 10036754B2 · Matray et al. · 2018 [cited by applicant]
US 10191060B2 · Chiu et al. · 2019 [cited by applicant]
US 10435563B2 · Matray et al. · 2019 [cited by applicant]
US 10617670B2 · Sapra et al. · 2020 [cited by applicant]
US 10709791B2 · Stayton et al. · 2020 [cited by applicant]
US 10834091B2 · Deninno et al. · 2020 [cited by applicant]
US 10865310B2 · Matray et al. · 2020 [cited by applicant]
US 10866244B2 · Matray et al. · 2020 [cited by applicant]
US 10954391B2 · Matray et al. · 2021 [cited by applicant]
US 10989715B2 · Matray et al. · 2021 [cited by applicant]
US 11013756B2 · Haruta et al. · 2021 [cited by applicant]
US 11084932B2 · Battrell et al. · 2021 [cited by applicant]
US 11142647B2 · Matray et al. · 2021 [cited by applicant]
US 11312736B1 · Matray et al. · 2022 [cited by applicant]
US 11352502B2 · Matray et al. · 2022 [cited by applicant]
US 11370922B2 · Matray et al. · 2022 [cited by applicant]
US 11377563B2 · Matray et al. · 2022 [cited by applicant]
US 11390754B2 · Singh et al. · 2022 [cited by applicant]
US 11434374B2 · Matray et al. · 2022 [cited by applicant]
US 11434377B2 · Matray et al. · 2022 [cited by applicant]
US 11453783B2 · Matray et al. · 2022 [cited by applicant]
US 11618906B2 · Steele et al. · 2023 [cited by applicant]
US 11685835B2 · Matray · 2023 [cited by applicant]
US 11827661B2 · Battrell et al. · 2023 [cited by applicant]
US 11874280B2 · Jackson et al. · 2024 [cited by applicant]
US 11931419B2 · Matray · 2024 [cited by applicant]
US 11945955B2 · Matray et al. · 2024 [cited by applicant]
US 12006438B2 · Singh et al. · 2024 [cited by applicant]
US 12018159B2 · Matray et al. · 2024 [cited by applicant]
US 20010018503A1 · Whipple et al. · 2001 [cited by applicant]
US 20020012947A1 · Bevers et al. · 2002 [cited by applicant]
US 20020099013A1 · Piccariello et al. · 2002 [cited by applicant]
US 20020142329A1 · Matray et al. · 2002 [cited by applicant]
US 20030054361A1 · Heller · 2003 [cited by applicant]
US 20030207208A1 · Uenishi · 2003 [cited by applicant]
US 20030207264A1 · Packard et al. · 2003 [cited by applicant]
US 20040014981A1 · Lugade et al. · 2004 [cited by applicant]
US 20040067498A1 · Chenna et al. · 2004 [cited by applicant]
US 20040096825A1 · Chenna et al. · 2004 [cited by applicant]
US 20040138467A1 · French et al. · 2004 [cited by applicant]
US 20040224372A1 · Li et al. · 2004 [cited by applicant]
US 20040241768A1 · Whitten et al. · 2004 [cited by applicant]
US 20050054024A1 · Lawrence · 2005 [cited by applicant]
US 20050123935A1 · Haugland et al. · 2005 [cited by applicant]
US 20060008822A1 · Manoharan et al. · 2006 [cited by applicant]
US 20060035302A1 · Lee · 2006 [cited by applicant]
US 20060063186A1 · Benson et al. · 2006 [cited by applicant]
US 20070042398A1 · Peng et al. · 2007 [cited by applicant]
US 20070077549A1 · Buller et al. · 2007 [cited by applicant]
US 20070148094A1 · Uzgiris · 2007 [cited by applicant]
US 20070269902A1 · Beechem et al. · 2007 [cited by applicant]
US 20080227939A1 · Mizoshita et al. · 2008 [cited by applicant]
US 20090253792A1 · Mickle et al. · 2009 [cited by applicant]
US 20090299070A1 · Berens et al. · 2009 [cited by applicant]
US 20100039684A1 · Kolb et al. · 2010 [cited by applicant]
US 20100092386A1 · Segev · 2010 [cited by applicant]
US 20100129800A1 · Aymami Bofarull et al. · 2010 [cited by applicant]
US 20100192312A1 · Cremer et al. · 2010 [cited by applicant]
US 20110144065A1 · Denardo et al. · 2011 [cited by applicant]
US 20110224516A1 · Romey et al. · 2011 [cited by applicant]
US 20120021454A1 · Bikker et al. · 2012 [cited by applicant]
US 20120116079A1 · Lukhtanov et al. · 2012 [cited by applicant]
US 20120126175A1 · Ueno et al. · 2012 [cited by applicant]
US 20130059343A1 · Cheung · 2013 [cited by applicant]
US 20130102021A1 · Beacham et al. · 2013 [cited by applicant]
US 20130119363A1 · Sasaki et al. · 2013 [cited by applicant]
US 20130137755A1 · Segev · 2013 [cited by applicant]
US 20130202536A1 · Mustaev et al. · 2013 [cited by applicant]
US 20130244891A1 · Waggoner et al. · 2013 [cited by applicant]
US 20140023590A1 · Gao et al. · 2014 [cited by applicant]
US 20140193504A1 · Wooley et al. · 2014 [cited by applicant]
US 20140275508A1 · Scarr et al. · 2014 [cited by applicant]
US 20150030541A1 · Rogers · 2015 [cited by applicant]
US 20150110715A1 · Eder et al. · 2015 [cited by applicant]
US 20150159198A1 · McGall et al. · 2015 [cited by applicant]
US 20150232615A1 · Kwiatkowski · 2015 [cited by applicant]
US 20150258217A1 · Caravan · 2015 [cited by applicant]
US 20160039850A1 · Segev · 2016 [cited by applicant]
US 20160176903A1 · Segev · 2016 [cited by applicant]
US 20160264737A1 · Bartholomew et al. · 2016 [cited by applicant]
US 20160327859A1 · Idei et al. · 2016 [cited by applicant]
US 20160347907A1 · Dose · 2016 [cited by applicant]
US 20170292957A1 · Matray · 2017 [cited by applicant]
US 20170326233A1 · Demeule et al. · 2017 [cited by applicant]
US 20180065998A1 · Battrell et al. · 2018 [cited by applicant]
US 20180092993A1 · Desai et al. · 2018 [cited by applicant]
US 20180141935A1 · Josel et al. · 2018 [cited by applicant]
US 20180312468A1 · Zhang et al. · 2018 [cited by applicant]
US 20190136065A1 · Singh et al. · 2019 [cited by applicant]
US 20190144678A1 · Matray et al. · 2019 [cited by applicant]
US 20190153232A1 · Matray et al. · 2019 [cited by applicant]
US 20190177549A1 · Matray et al. · 2019 [cited by applicant]
US 20190300716A1 · Matray et al. · 2019 [cited by applicant]
US 20200032139A1 · Behrendt et al. · 2020 [cited by applicant]
US 20200164085A1 · Brandish et al. · 2020 [cited by applicant]
US 20200222554A1 · Matray et al. · 2020 [cited by applicant]
US 20200330610A1 · Desai et al. · 2020 [cited by applicant]
US 20200353089A1 · Matray · 2020 [cited by applicant]
US 20200353094A1 · Matray · 2020 [cited by applicant]
US 20200360526A1 · Matray · 2020 [cited by applicant]
US 20210032277A1 · Matray et al. · 2021 [cited by applicant]
US 20210032474A1 · Matray et al. · 2021 [cited by applicant]
US 20210095130A1 · Matray et al. · 2021 [cited by applicant]
US 20210096135A1 · Matray et al. · 2021 [cited by applicant]
US 20210109104A1 · Jackson et al. · 2021 [cited by applicant]
US 20210128591A1 · Matray · 2021 [cited by applicant]
US 20210128739A1 · Matray · 2021 [cited by applicant]
US 20210139440A1 · Ramsden et al. · 2021 [cited by applicant]
US 20210253864A1 · Matray et al. · 2021 [cited by applicant]
US 20210261782A1 · Matray et al. · 2021 [cited by applicant]
US 20210285953A1 · Matray et al. · 2021 [cited by applicant]
US 20210340380A1 · Matray et al. · 2021 [cited by applicant]
US 20210395530A1 · Matray et al. · 2021 [cited by applicant]
US 20220160887A1 · Matray et al. · 2022 [cited by applicant]
US 20220168433A1 · Matray et al. · 2022 [cited by applicant]
US 20220168435A1 · Matray et al. · 2022 [cited by applicant]
US 20220175951A1 · Boitano et al. · 2022 [cited by applicant]
US 20220220314A1 · Singh et al. · 2022 [cited by applicant]
US 20220227794A1 · Matray et al. · 2022 [cited by applicant]
US 20220305127A1 · Thomas et al. · 2022 [cited by applicant]
US 20220372297A1 · Matray et al. · 2022 [cited by applicant]
US 20220380603A1 · Matray et al. · 2022 [cited by applicant]
US 20220402963A1 · Matray et al. · 2022 [cited by applicant]
US 20230012304A1 · Matray et al. · 2023 [cited by applicant]
US 20230129481A1 · Matray et al. · 2023 [cited by applicant]
US 20240043455A1 · Battrell et al. · 2024 [cited by applicant]
US 20240092820A1 · Matray et al. · 2024 [cited by applicant]
US 20240132725A1 · Sherif · 2024 [cited by applicant]
US 20240207423A1 · Matray · 2024 [cited by applicant]
US 20240210408A1 · Jackson et al. · 2024 [cited by applicant]
US 20240248094A1 · Matray et al. · 2024 [cited by applicant]
US 20240255514A1 · Matray et al. · 2024 [cited by applicant]
CA 2263671A1 · 1998 [cited by applicant]
CN 102174078A · 2011 [cited by applicant]
CN 103319378A · 2013 [cited by applicant]
CN 104072727A · 2014 [cited by applicant]
CN 105917226A · 2016 [cited by applicant]
CN 106589005A · 2017 [cited by applicant]
CN 107709470A · 2018 [cited by applicant]
CN 109153860A · 2019 [cited by applicant]
EP 0708837B1 · 2006 [cited by applicant]
GB 2372256A · 2002 [cited by applicant]
GB 2554666A · 2018 [cited by applicant]
JP S61207395A · 1986 [cited by applicant]
JP H04282391A · 1992 [cited by applicant]
JP 2000017183A · 2000 [cited by applicant]
JP 2014527071A · 2014 [cited by applicant]
JP 2017537266A · 2016 [cited by applicant]
JP 2017504659A · 2017 [cited by applicant]
JP 2017124994A · 2017 [cited by applicant]
JP 2018507863A · 2018 [cited by applicant]
JP 2018515628A · 2018 [cited by applicant]
JP 2019516807A · 2019 [cited by applicant]
JP 2019516821A · 2019 [cited by applicant]
JP 2021527911A · 2020 [cited by applicant]
JP 2021518410A · 2021 [cited by applicant]
JP 7069033B2 · 2022 [cited by applicant]
JP 7239904B2 · 2023 [cited by applicant]
KR 101041446B1 · 2011 [cited by applicant]
KR 1020150007795A · 2015 [cited by applicant]
KR 20160022358A · 2016 [cited by applicant]
KR 1020200133374A · 2020 [cited by applicant]
KR 102530707B1 · 2023 [cited by applicant]
SU 1121931A1 · 1988 [cited by applicant]
WO WO9502700A1 · 1995 [cited by applicant]
WO WO9506731A2 · 1995 [cited by applicant]
WO WO9832463A2 · 1998 [cited by applicant]
WO WO0173123A2 · 2001 [cited by applicant]
WO WO0222883A1 · 2002 [cited by applicant]
WO WO02083954A1 · 2002 [cited by applicant]
WO WO2004007751A2 · 2004 [cited by applicant]
WO WO2007094135A1 · 2007 [cited by applicant]
WO WO2009113645A1 · 2009 [cited by applicant]
WO WO2009132020A2 · 2009 [cited by applicant]
WO WO2010026957A1 · 2010 [cited by applicant]
WO WO2013012687A2 · 2013 [cited by applicant]
WO WO2014102803A1 · 2014 [cited by applicant]
WO WO2014147642A1 · 2014 [cited by applicant]
WO WO2015091953A1 · 2015 [cited by applicant]
WO WO2016183185A1 · 2016 [cited by applicant]
WO WO2017003639A2 · 2017 [cited by applicant]
WO WO2017062271A2 · 2017 [cited by applicant]
WO WO2017089890A1 · 2017 [cited by applicant]
WO WO2017177065A2 · 2017 [cited by applicant]
WO WO2017197144A1 · 2017 [cited by applicant]
WO WO2018045278A1 · 2018 [cited by applicant]
WO WO2018060722A1 · 2018 [cited by applicant]
WO WO2019126691A1 · 2019 [cited by applicant]
WO WO2019140227A1 · 2019 [cited by applicant]
WO WO2019182765A1 · 2019 [cited by applicant]
WO WO2019182766A1 · 2019 [cited by applicant]
WO WO2020219959A1 · 2020 [cited by applicant]
Takakusa Hideo et al: “Design and Synthesis of an Enzyme-Cleavable Sensor Molecule for Phosphodiesterase Activity Based on Fluorescence Resonance Energy Transfer”, Journal of The American Chemical Society, vol. 124, No.… [cited by applicant]
Vinogradov Alexander A. et al: “Total synthesis and biochemical characterization of mirror image barnase”, Chemical Science, vol. 6, No. 5, Jan. 1, 2015 (Jan. 1, 2015), pp. 2997-3002, XP055777908. [cited by applicant]
Rui Zhang et al: “FRET Imaging of Enzyme-Responsive HPMA Copolymer Conjugate”, Macromolecular Bioscience, vol. 17, No. 1, Jan. 1, 2017 (Jan. 1, 2017), p. 1-8, 1600125, XP055591040. [cited by applicant]
“What is an Analyte?,” Google Search, dated Mar. 22, 2018, retrieved from https://www.google.com/search?q-what+is+an+analyte&rlz=1CIGCEB_enUS775US775&oq=what+is+an+analyte&aqs=chrome . . . 69i57j015.3231j0j7&s . . . 2 p… [cited by applicant]
Arian et al., “1,9-Dialkoxyanthracene as a 1O2-Sensitive Linker,” [cited by applicant]
Aviñó et al., “Solid-phase synthesis of oligomers carrying several chromophore units linked by phosphodiester backbones,” [cited by applicant]
Avirah et al., “Infrared Absorbing Croconaine Dyes: Synthesis and Metal Ion Binding Properties,” [cited by applicant]
Babitskaya et al., “Bromoacyl Analogues of Phosphatidycholine with Intramolecular Fluorescence Quenching and Their Use as Substrates for Continuous Monitoring of Phospholipase A2 Activity,” [cited by applicant]
Bag et al., “Triazolyl-donor-acceptor chromophore-decorated unnatural amino acids and peptides: FRET events in a β-turn conformation,” [cited by applicant]
Bargh et al., “Cleavable linkers in antibody-drug conjugates,” [cited by applicant]
Beaucage et al., “The Functionalization of Oligonucleotides via Phosphoramidite Derivatives,” [cited by applicant]
Becker et al., “New Thermotropic Dyes Based on Amino-Substituted Perylendicarboximides,” [cited by applicant]
Bergstrom et al., “A novel, highly potent HER2-targeted antibody-drug conjugate (ADC) for the treatment of low HER2-expressing tumors and combination with trastuzumab-based regimens in HER2-driven tumors,” Mersana Thera… [cited by applicant]
Bergstrom et al., “XMT-1522 induces tumor regressions in pre-clinical models representing HER2-positive and HER2 low-expressing breast cancer,” Mersana Therapeutics, Abstract P4-14-28, 2015, 1 page. [cited by applicant]
Bergstrom et al., “A NaPi2b Antibody-Drug Conjugate Induces Durable Complete Tumor Regressions in Patient-Derived Xenograft Models of NSCLC,” [cited by applicant]
Bergstrom et al., “Potent Promise,” [cited by applicant]
Boldyrev et al., “Synthesis and Characteristics of New Fluorescent Probes Based on Cardiolipin,” [cited by applicant]
Braeckmans et al., “Three-dimensional fluorescence recovery after photobleaching with the confocal scanning laser microscope,” [cited by applicant]
Braga et al., “Intracellular macromolecular mobility measured by fluorescence recovery after photobleaching with confocal laser scanning microscopes,” [cited by applicant]
Breul et al., “Fluorescent monomers as building blocks for dye labeled polymers: synthesis and application in energy conversion, biolabeling and sensors,” Chem. Soc. Rev. 42(12):5366-5407, 2013. [cited by applicant]
Brinkley, “A brief survey of methods for preparing protein conjugates with dyes, haptens, and cross-linking reagents,” [cited by applicant]
Buckhout-White et al., “Assembling programmable FRET-based photonic networks using designer DNA scaffolds,” [cited by applicant]
CAPLUS Accession No. 1975: 171341, Holy, “Nucleic acid components and their analogs. CLXXII. Aliphatic analogs of nucleosides, nucleotides, and oligonucleotides,” [cited by applicant]
CAPLUS Accession No. 1991:467753, Mielewczyk et al., “5′ end fluorescent labelling of oligonucleotides with riboflavin-derived phosphitylating reagent,” [cited by applicant]
CAPLUS Accession No. 1995:665426, Chen et al., “Synthesis of Novel Phosphoramidite Reagents for the Attachment of Antisense Oligonucleotides to Various Regions of the Benzophenanthridine Ring System,” [cited by applicant]
CAPLUS Accession No. 1995:733249, WO9506731A2, filed Mar. 9, 1995. (1 page). [cited by applicant]
CAPLUS Accession No. 1995:849926, Reed et al., “Structure-Activity Relationships of Cytotoxic Cholesterol-Modified DNA Duplexes,” [cited by applicant]
CAPLUS Accession No. 1997:497709, Puri et al., “Synthesis of 5′-polyarene-tethered oligo-DNAs and the thermal stability and spectroscopic properties of their duplexes and triplexes,” [cited by applicant]
CAS Registry No. 862288-26-4, American Chemical Society, 2021. (1 page). [cited by applicant]
Chang et al., “A General Approach for Generating Fluorescent Probes to Visualize Piconewton Forces at the Cell Surface,” [cited by applicant]
Chattopadhyay et al., “Brilliant Violet Fluorophores: A New Class of Ultrabright Fluorescent Compounds for Immunofluorescence Experiments,” [cited by applicant]
Chen et al., “Synthesis and properties of new segmented block poly(urethane-urea)s containing phosphatidylcholine analogues and polybutadienes,” [cited by applicant]
Chen et al., “Synthesis of Novel Phosphoramidite Reagents for the Attachment of Antisense Oligonucleotides to Various Regions of the Benzophenanthridine Ring System,” [cited by applicant]
Chong et al., “Oxygen Quenching of Pyrene-Lipid Fluorescence in Phosphatidylcholine Vesicles—A Probe for Membrane Organization,” [cited by applicant]
Ciccotelli et al., “Polyguanine-conjugated antigens for scavenger receptor targeting and self-adjuvanting vaccines (VAC13P.1125),” [cited by applicant]
Cuppoletti et al., “Oligomeric fluorescent labels for DNA,” [cited by applicant]
Dai et al., “DNA-polyfluorophore excimers as sensitive reporters for esterases and lipases,” [cited by applicant]
Damian et al., “Synthesis and DNA Interaction of Platinum Complex/Peptide Chimera as Potential Drug Candidates,” [cited by applicant]
De Vos et al., “New Non Nucleosidic Phosphoramidites for The Solid Phase Multi-Labelling of Oligonucleotides: Comb- and Multifork-Like Structures,” [cited by applicant]
Dioubankova et al., “Oligonucleotides containing new fluorescent 1-phenylethynylpyrene and 9,10-bis(phenylethynyl)anthracene uridine-2′-carbamates: synthesis and properties,” [cited by applicant]
DiVittorio et al., “Synthetic peptides with selective affinity for apoptotic cells,” [cited by applicant]
Doi et al., “Hetero-Selective DNA-Like Duplex Stabilized by Donor-Acceptor Interactions,” [cited by applicant]
Drescher et al., “General Synthesis and Aggregation Behaviour of New Single-Chain Bolaphospholipids: Variations in Chain and Headgroup Structures,” [cited by applicant]
Dropulic et al., “Update on New Antivirals Under Development for the Treatment of Double-Stranded DNA Virus Infections,” Clinical Pharmacology & Therapeutics 88(5):610-619, Nov. 2010. [cited by applicant]
Dubrovsky, “Semiconductor nanoparticles as reporters in multiplexed immunoassay and cell analysis,” [cited by applicant]
Finniss et al., “A versatile acid-labile linker for antibody-drug conjugates,” Med. Chem, Commun; 5; Apr. 1, 2014, 4 pages. [cited by applicant]
Franceschin et al., “Synthesis of a Dibromoperylene Phosphoramidite Building Block and Its Incorporation at the 5′ End of a G-Quadruplex Forming Oligonucleotide: Spectroscopic Properties and Structural Studies of the Re… [cited by applicant]
Franzini et al., “Identification of Structure-Activity Relationships from Screening a Structurally Compact DNA-Encoded Chemical Library,” [cited by applicant]
Gao et al., “Libraries of Composite Polyfluors Built from Fluorescent Deoxyribosides,” [cited by applicant]
Gao et al., “Modified DNA Analogues That Sense Light Exposure with Color Changes,” [cited by applicant]
Gordon et al., “Analysis of simulated and experimental fluorescence recovery after photobleaching. Data for two diffusing components,” [cited by applicant]
Griesang et al., “Four-Color, Enzyme-Free Interrogation of DNA Sequences with Chemically Activated, 3′-Fluorphore-Labeled Nucleotides,” [cited by applicant]
Gupta et al., “Dendrimers: Novel Polymeric Nanoarchitectures for Solubility Enhancement,” [cited by applicant]
Guryev et al., “Control of the Fluorescence of Dye-Antibody Conjugates by (2-Hydroxypropyl)β-cyclodextrin in Fluorescence Microscopy and Flow Cytometry,” [cited by applicant]
Hanhela et al., “Synthesis and Evaluation of Fluorescent Materials for Colour Control of Peroxyoxalate Chemiluminescence. III. Yellow and Red Fluorescent Emitters,” [cited by applicant]
Haraguchi, “Live Cell Imaging: Approaches for Studying Protein Dynamics in Living Cells,” [cited by applicant]
Hasegawa et al., “Cysteine, histidine and glycine exhibit anti-inflammatory effects in human coronary arterial endothelial cells,” [cited by applicant]
Irani et al., “Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases,” [cited by applicant]
Jain et al. “Current ADC Linker Chemistry,” [cited by applicant]
Johansson, “Choosing Reporter-Quencher Pairs for Efficient Quenching Through Formation of Intramolecular Dimers,” [cited by applicant]
Kashida et al., “A Cationic Dye Triplet as a Unique “Glue” That Can Connect Fully Matched Termini of DNA Duplexes,” [cited by applicant]
Khandare et al., “Polymer-drug conjugates: Progress in polymeric prodrugs,” [cited by applicant]
Kolpashchikov, “Binary Probes for Nucleic Acid Analysis,” [cited by applicant]
Koo et al., “Fluorescent DNA chemosensors: identification of bacterial species by their volatile metabolites,” [cited by applicant]
Kozma et al., “Fluorescent Ligands for Adenosine Receptors,” [cited by applicant]
Kozytska et al., “Discovery of the novel, homogenous payload platform Dolasynthen for Antibody-Drug Conjugates,” Mersana Therapeutics, Abstract #272, 2018. (1 page). [cited by applicant]
Krueger at al., “Fluorescent Amino Acids: Modular Building Blocks for the Assembly of New Tools for Chemical Biology,” [cited by applicant]
Lapeyre et al., “Aryldithioethyloxycarbonyl (Ardec): A New Family of Amine Protecting Groups Removable under Mild Reducing Conditions and Their Applications to Peptide Synthesis,” [cited by applicant]
Lee et al., “Monitoring the Hydrophobic Interactions of Internally Pyrene-Labeled Poly(ethylene oxide)s in Water by Fluorescence Spectroscopy,” [cited by applicant]
Lee et al., “The spectroscopic analysis for binding of amphipathic and antimicrobial model peptides containing pyrenylalanine and tryptophan to lipid bilayer,” [cited by applicant]
Leung et al., “7-Amino-4-Methyl-6-Sulfocoumarin-3-Acetic Acid: A Novel Blue Fluorescent Dye for Protein Labeling,” [cited by applicant]
Lewis et al., “Orientation Control of Fluorescence Resonance Energy Transfer Using DNA as a Helical Scaffold,” [cited by applicant]
Li et al., “Polymeric Drugs: Advances in the development of pharmacologically active polymers,” [cited by applicant]
Li et al., “Responsive nanogel-based dual fluorescent sensors for temperature and Hg2+ ions with enhanced detection sensitivity,” [cited by applicant]
Liso et al., “Polymeric drugs derived from Ibuprofen with improved antiinflammatory profile,” [cited by applicant]
Liu et al., “Detection of prostate-specific membrane antigen on HUVECs in response to breast tumor-conditioned medium,” [cited by applicant]
Liu et al., “DNA-Based Micelles: Synthesis, Micellar Properties and Size-Dependent Cell Permeability,” [cited by applicant]
Liu et al., “Imidazole inhibits autophagy flux by blocking autophagic degradation and triggers apoptosis via increasing FoxO3a-Bim expression,” [cited by applicant]
Liu et al., “Increased Cytotoxicity and Decreased In Vivo Toxicity of FdUMP[10] Relative to 5-FU,” [cited by applicant]
Luo et al., “Sensitive and rapid quantification of C-reactive protein using quantum dot-labeled microplate immunoassay,” [cited by applicant]
Ivnitski et al., “Introducing charge transfer functionality into prebiotically relevant β-sheet peptide fibrils,” [cited by applicant]
Malakhov et al., “1-(Phenylethynyl)pyrene and 9,10-Bis(phenylethynyl)anthracene, Useful Fluorescent Dyes for DNA Labeling: Excimer Formation and Energy Transfer,” [cited by applicant]
Marras et al., “Efficiencies of fluorescence resonance energy transfer and contact-mediated quenching in oligonucleotide probes,” [cited by applicant]
Masuko et al., “Fluorescence resonance energy transfer from pyrene to perylene labels for nucleic acid hybridization assays under homogenous solution conditions,” [cited by applicant]
McKinlay et al., “Cell-Penetrating, Guanidinium-Rich Oligophosphoesters: Effective and Versatile Molecular Transporters for Drug and Probe Delivery,” [cited by applicant]
Mersana Therapeutics, URL=http://www.mersana.com, download date Jan. 3, 2019, 9 pages. [cited by applicant]
Midoux et al., “Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers,” [cited by applicant]
Mielewczyk et al., “5′ end fluorescent labelling of oligonucleotides with riboflavin-derived phosphitylating reagent,” [cited by applicant]
Molotkovsky et al., “Perylenoyl- and Anthrylvinyl-Labeled Lipids as Membrane Probes,” [cited by applicant]
Moss, “Nomenclature of Fused and Bridged Fused Ring Systems,” [cited by applicant]
Mthembu et al., “Breaking a Couple: Disulfide Reducing Agents,” [cited by applicant]
Nolting, “Linker Technology for Antibody-Drug Conjugates,” in Ducry (ed.), [cited by applicant]
Nussbaumer et al., “Amplification of Chirality by Supramolecular Polymerization of Pyrene Oligomers,” [cited by applicant]
Oh et al., “Low-dose guanidine and pyridostigmine: relatively safe and effective long-term symptomatic therapy in Lambert-Eaton myasthenic syndrome,” [cited by applicant]
Paris et al., “Probing DNA sequences in solution with a monomer-excimer fluorescence color change,” [cited by applicant]
Pawelczyk et al., “Molecular Consortia-Various Structural and Synthetic Concepts for More Effective Therapeutics Synthesis,” [cited by applicant]
Pelegrin et al., “Antiviral Monoclonal Antibodies: Can They Be More Than Simple Neutralizing Agents?” [cited by applicant]
Petersen et al., “Acyclic, achiral enamide nucleoside analogues. The importance of the C=C bond in the analogue for its ability to mimic natural nucleosides,” [cited by applicant]
Petreus et al., “Polyester imides containing main-chain phosphorus,” [cited by applicant]
Phares et al., “Improving the Stability and Sensing of Electrochemical Biosensors by Employing Trithiol-Anchoring Groups in a Six-Carbon Self-Assembled Monolayer,” [cited by applicant]
Poupart et al., “Aminopropargyl derivative of terpyridine-bis(methyl-enamine) tetraacetic acid chelate of europium (Eu (TMT)-AP3): a new reagent for fluorescent labelling of proteins and peptides,” Org. Biomol. Chem. 4:… [cited by applicant]
Pownall et al., “Kinetics of Spontaneous and Plasma-Stimulated Sphingomyelin Transfer,” [cited by applicant]
PubChem, “US20100012929A1-20100121-C00010_4,” SID No. 140452858, retrieved Mar. 29, 2016 from URL https://pubchem.ncbi.nlm.nih.gov/substance/140452858#sectio . . . , 6 pages. [cited by applicant]
Puri et al., “Synthesis of 5′-polyarene-tethered oligo-DNAs and the thermal stability and spectroscopic properties of their duplexes and triplexes,” [cited by applicant]
Reed et al., “Structure-Activity Relationships of Cytotoxic Cholesterol-Modified DNA Duplexes,” [cited by applicant]
Ren et al., “An Antisense Oligodeoxynucleotide-Doxorubicin Conjugate: Preparation and Its Reversal Multidrug Resistance of Human Carcinoma Cell Line In Vitro,” Nucleosides, Nucleotides & Nucleic Acids 23(10): 1595-1607,… [cited by applicant]
RN 230952-79-1, Registry Database Compound, 1999. [cited by applicant]
Rochat et al., “Water-Soluble Cationic Conjugated Polymers: Response to Electron-Rich Bioanalytes,” [cited by applicant]
Rupcich et al., “Quenching of Fluorophore-Labeled DNA Oligonucleotides by Divalent Metal Ions: Implications for Selection, Design, and Applications of Signaling Aptamers and Signaling Deoxyribozymes,” J. Am. Chem. Soc. … [cited by applicant]
Saito et al., “Dual-labeled oligonucleotide probe for sensing adenosine via FRET: A novel alternative to SNPs genotyping,” Chem. Commun.:2133-2135, 2007. [cited by applicant]
Samal et al., “Cationic polymers and their therapeutic potential,” [cited by applicant]
Shuey et al., “Cyclohexanediol Bisphosphates as Models for Phospholipid-Metal Ion Binding Sites,” [cited by applicant]
Shuman et al., “Bacterial DNA repair by non-homologous end joining,” [cited by applicant]
Singh et al., “Multiplexed measurement of membrane protein populations,” [cited by applicant]
Stewart et al., “The Fluorescence of a Chelating Two-Photon-Absorbing Dye is Enhanced with the Addition of Transition Metal Ions but Quenched in the Presence of Acid,” [cited by applicant]
STIC Search Report from American Chemical Society, for U.S. Appl. No. 17/255,353, dated Sep. 7, 2023. (143 pages). [cited by applicant]
Striebel et al., “Enhancing sensitivity of human herpes virus diagnosis with DNAmicroarrays using dendrimers,” [cited by applicant]
Stuart et al., “Site-Specific DNA-Doxorubicin Conjugates Display Enhanced Cytotoxicity to Breast Cancer Cells,” [cited by applicant]
Sun et al., “Dual-Color Fluorescence Imaging of Magnetic Nanoparticles in Live Cancer Cells Using Conjugated Polymer Probes,” [cited by applicant]
Sun et al., “High yield production of high molecular weight poly(ethylene glycol)/ α-cyclodextrin polyrotaxanes by aqueous one-pot approach,” [cited by applicant]
Sun et al., “Self-assembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA delivery,” [cited by applicant]
Sun et al., “Ultrabright and Multicolorful Fluorescence of Amphiphilic Polyethyleneimine Polymer Dots for Efficiently Combined Imaging and Therapy,” [cited by applicant]
Tabujew et al., “Chapter One: Functionalization of Cationic Polymers for Drug Delivery Applications,” [cited by applicant]
Teo et al., “Polyfluorophores on a DNA Backbone: A Multicolor Set of Labels Excited at One Wavelength,” [cited by applicant]
Teyssot et al., “Aromatic Nitrogen Donors for Efficient Copper(1)-NHC CuAAC under Reductant-Free Conditions,” [cited by applicant]
Tram et al., “Oligonucleotide Labeling Using BODIPY Phosphoramidite,” [cited by applicant]
Vybornyi et al., “Formation of Two-Dimensional Supramolecular Polymers by Amphiphilic Pyrene Oligomers,” [cited by applicant]
Wang et al., “Cruciforms: Assembling Single Crystal Micro- and Nanostructures from One to Three Dimensions and Their Applications in Organic Field-Effect Transistors,” [cited by applicant]
Wang et al., “DNA Polyfluorophores for Real-Time Multicolor Tracking of Dynamic Biological Systems,” [cited by applicant]
Wang et al., Fluorescence-Based Evaluation of the Partitioning of Lipids and Lipidated Peptides into Liquid-Ordered Lipid Microdomains: A Model for Molecular Partitioning into “Lipid Rafts,” [cited by applicant]
Wang et al., “Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis,” [cited by applicant]
Wang, “Modern Synthetic Methods and Technologies of Polymers,” Common Knowledge Evidence, Tongji University Press, 1st Edition, Jul. 2013, pp. 210-211. (includes portion of Chinese Office Action with English Summary of … [cited by applicant]
Wilson et al., “Efficient Quenching of Oligomeric Fluorophores on a DNA Backbone,” [cited by applicant]
Wilson et al., “Oligodeoxyfluorosides: Strong Sequence of Dependence of Fluorescence Emission,” [cited by applicant]
Winiger et al., “Long-Distance Electronic Energy Transfer in Light-Harvesting Supramolecular Polymers,” [cited by applicant]
Wu Yi et al., “ [cited by applicant]
Xu et al., “Synthesis of [D-Pyrenylalanine4,4′]gramicidin S by Solid-Phase-Synthesis and Cyclization-Cleavage Method with Oxime Resin,” [cited by applicant]
Yu et al., “Targeted Delivery of an Anti-Inflammatory PDE4 Inhibitor to Immune Cells via an Antibody-drug Conjugate,” Molecular Therapy 24(12):2078-2089, Dec. 2016. [cited by applicant]
Yurkovetskiy et al., “Advantages of Polyacetal Polymer-based Antibody Drug Conjugates: Application to Low Expression Targets,” Mersana Therapeutics, technical paper #2645, 2014, 1 page. [cited by applicant]
Zhao et al., “Mussel-Inspired One-Pot Synthesis of a Fluorescent and Water-Soluble Polydopamine-Polyethyleneimine Copolymer,” Macromol. Rapid Commun. 36:909-915, 2015. [cited by applicant]